Gedeon Richter Plc - Product Pipeline Review - Q1 2011

Global Markets Direct, May 2011, Pages: 60

Gedeon Richter Plc – Product Pipeline Review – Q1 2011

Summary

Global Market Direct’s pharmaceuticals report, “Gedeon Richter Plc. - Product Pipeline Review - Q1 2011” provides data on the company’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Gedeon Richter Plc. - Brief company overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Gedeon Richter Plc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Gedeon Richter Plc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Gedeon Richter Plc.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Gedeon Richter Plc.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Gedeon Richter Plc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Gedeon Richter Plc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Gedeon Richter Plc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Gedeon Richter Plc. and identify potential opportunities in those areas.

List of Tables
List of Figures
Gedeon Richter Plc Snapshot
Gedeon Richter Plc Overview
Key Information
Key Facts
Gedeon Richter Plc – Research and Development Overview
Key Therapeutic Areas
Gedeon Richter Plc – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Gedeon Richter Plc – Pipeline Products Glance
Gedeon Richter Plc – Late Stage Pipeline
Phase III Products/Combination Treatment Modalities
Gedeon Richter Plc Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Gedeon Richter Plc – Drug Profiles
Esmya
Product Description
Mechanism of Action
R&D Progress
Cariprazine
Product Description
Mechanism of Action
R&D Progress
PGL3001
Product Description
Mechanism of Action
R&D Progress
Radiprodil
Product Description
Mechanism of Action
R&D Progress
PGL2001
Product Description
Mechanism of Action
R&D Progress
Gedeon Richter Plc – Pipeline Analysis
Gedeon Richter Plc – Pipeline Products by Therapeutic Class
Gedeon Richter Plc - Pipeline Products By Target
Gedeon Richter Plc – Pipeline Products by Route of Administration
Gedeon Richter Plc – Pipeline Products by Molecule Type
Gedeon Richter Plc – Recent Pipeline Updates
Gedeon Richter Plc - Dormant Projects
Gedeon Richter Plc – Company Statement
Gedeon Richter Plc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Financial Deals Landscape
Gedeon Richter Plc, Deals Volume Summary, 2004 to YTD 2011
Gedeon Richter Plc, Deals Summary By Region, 2004 to YTD 2011
Gedeon Richter Plc, Deals Summary, 2004 to YTD 2011
Gedeon Richter Plc Detailed Deal Summary
Acquisition
Gedeon Richter Acquires 29.6% Stake In Grodziskie Zaklady Farmaceutyczne
Hungaropharma Acquires Medimpex Pharmaceutical From Gedeon And EGIS
Gedeon Richter Acquires 80.62% Stake Of Akrihin
Gedeon Richter Acquires 95.78% Stake In Pharmafarm
Gedeon Richter And Helm Acquires Strathmann Biotec
Armedica Trading Acquires Dita Group
Gedeon Richter Acquires 8.33% Stake In Hungaropharma
Gedeon Richter Terminates The Acquisition Of 99.65% Of Shares Of Polpharma
HRA And Gedeon Richter Enter Into Marketing And Distribution Agreement
HRA Pharma Enters Into Co-Marketing Agreement With Gedeon Richter
Gedeon Richter Enters Into A Distribution Agreement With Orexo
ProStrakan Enters Into Distribution Agreement With Gedeon Richter
Gedeon Richter Enters Into An Agreement With Repros Therapeutics
KV Pharmaceutical Acquires Rights From Gedeon Richter
Themis Medicare And Gedeon Richter Form Joint Venture
Gedeon Richter Extends An Agreement With Chemical Diversity Labs
Licensing Agreements
KV Pharmaceutical Enters Into Licensing Agreement With Gedeon Richter
DSM Biologics And Crucell Enter Into Licensing Agreement With Gedeon Richter
Gedeon Richter Enters Into Licensing Agreement With Mitsubishi Pharma
KV Pharmaceutical Enters Into Licensing Agreement With Gedeon Richter
Gedeon Richter, Gedeon Richter USA And Forest Laboratories Enter Into Collaboration Agreement
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Gedeon Richter Plc – Pipeline by Therapy Area and Indication, 2011
Gedeon Richter Plc – Pipeline by Stage of Development, 2011
Gedeon Richter Plc – Monotherapy Products in Pipeline, 2011
Gedeon Richter Plc – Phase III, 2011
Gedeon Richter Plc - Phase II, 2011
Gedeon Richter Plc - Phase I, 2011
Gedeon Richter Plc - Pipeline By Therapeutic Class, 2011
Gedeon Richter Plc - Pipeline By Target, 2011
Gedeon Richter Plc – Pipeline By Route of Administration, 2011
Gedeon Richter Plc – Pipeline By Molecule Type, 2011
Gedeon Richter Plc – Recent Pipeline Updates, 2011
Gedeon Richter Plc - Dormant Developmental Projects, 2010
Gedeon Richter Plc, Other Locations
Gedeon Richter Plc, Subsidiaries
Gedeon Richter Plc, Deals Summary, 2004 to YTD 2011
Gedeon Richter Plc, Deals Summary by Region, 2004 to YTD 2011
Gedeon Richter Plc, Deals Summary, 2004 to YTD 2011

List of Figures
Gedeon Richter Plc – Pipeline by Therapy Area and Indication, 2011
Gedeon Richter Plc – Pipeline by Stage of Development, 2011
Gedeon Richter Plc – Monotherapy Products in Pipeline, 2011
Gedeon Richter Plc – Pipeline By Therapeutic Class, 2011
Gedeon Richter Plc - Pipeline By Target, 2011

Customers who bought this item also bought

• Top Five Global Software Companies: Performance, Strategies and Competitive Analysis
• Apple, Inc. - Strategies, Financial Outlook and Competitive Benchmark Analysis
• Hewlett-Packard Company - Strategies, Financial Outlook and Competitive Benchmark Analysis
• eBay - Strong Execution
• Scientific Games Corporation - Company Analysis
• Ixia - Company Analysis
• Amazon - Point of Realization in 2013?
• SunGard - Profile - US
• Insight into Samsung Electronics' Notebook PC Business Model
• US - Accenture - Company Profile